Anti-CagA antibodies are associated with atrophie gastritis in a population at high gastric cancer risk: A morphometric study by computerized image analysis

Italian Journal of Gastroenterology and Hepatology

Volumn 29, Issue 5, 1997, Pages 409-414

  Bonvicini, F ^a,b,c,d   Baldini, L ^a,b,c,d   Pretolani, S ^a,b,c,d   Figura, N ^a,b,c,d   Epifanio, G ^a,b,c,d   Armuzzi, A ^a,b,c,d   Miglio, F ^a,b,c,d   Gasbarrini, G ^a,b,c,d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF SIENA   (Italy)

Author keywords

Cytotoxic strains computerized image analysis; Helicobacter pylori infection

Indexed keywords

ANTIBODY; UREASE;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; ATROPHIC GASTRITIS; CANCER RISK; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOBLOTTING; INFLAMMATORY CELL; LAMINA PROPRIA; MALE; MONONUCLEAR CELL; MORPHOMETRICS; POLYMORPHONUCLEAR CELL; SCORING SYSTEM; STOMACH BIOPSY; STOMACH CANCER; STOMACH GLAND;

ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; FEMALE; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; HELICOBACTER PYLORI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0031406435     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992; 102:720-7.
2. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl Med 1991;325:1127-31.
3. Nomura A, Stemmermann GN, Chyou P, Kalo I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
4. Talley NJ, Zinsmeister AR, Weaver A, Di Magno EP, Carpenter
5. HA, Perez-Perez GI, et al. Gastric Adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst 1991;83:1734-9.
6. Forman D, Newell DG, Fullerton F, Yarnell JWG Stacey AR, Wald N, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J 1991;302:1302-5.
7. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - First American Cancer Society Award lecture on cancer epidemiology and prevention. Cancer Res 1992;52:6735-4îO.
8. Graham DY, Malaty HM, Go MF. Are there susceptible hosts to Helicobacter pylori infection? Scand J Gastroenterol 1994;205 (suppl. 29):6-10.
9. Telford J, Ghiara P, Dell'Orco M, Comanducci M, Burroni D, Bugnoli M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994;179:1653-8.
10. Xiang Z, Censini S, Bayeli PF, Telford JL, Figura N, Rappuoli R, et al. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995;63:94-8.
11. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sei USA / 1993;90:5791-5.
12. Ching CK, Wong BCY, Kwok E, Ong L, Covacci A, Lam SK. Prevalence of a CagA bearing Helicobacter pylori strains detected by the anti-CagA assay in patients with peptic ulcer disease and in controls. Am J Gastroenterol 1996;91(5):949-53.
13. Censini S, Lange C, Xiang Z, Crabtree J, Ghiara P, Borodovsky M, et al. Cag, a pathogenicity island of Helicobacter pylori encodes type I-specific and disease associated virulence factors. Proc Natl Acad Sei USA 1996;93:14648-53.
14. Yamaoka Y, Kita M, Kodama T, Saeai N, Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996; 110:1744-52.
15. Kuipers EJ, Perez-Perez GI, Meuwissen SGM, Blaser MJ. Helicobacter pylori and atrophie gastritis: importance of the CagA status. J Natl Cancer Inst 1995;87:1777-80.
16. Beales IL, Crabtree JE, Scunes D, Covacci A, Calam J. Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1996;8:645-9.
17. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995;55:2111-5.
18. Sipponen P, Hyvärinen H. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol 1993;196 (Suppl. 128):3-6.
19. Andrew A, Wyatt JI, Dixon MF. Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology 1994;25(Suppl. 4):317-22.
20. Jackson CE, Brownlee RW, Schuman BM, Micheloni F, Ghironzi GC. Observations on gastric cancer in San Marino. I. Familiar Factors. Cancer 1980;45:599-602.
21. Gasbarrini G, Pretolani S, Bonvicini F, Gatto MRA, Tonelli E, Mégraud F, et al. A population-based study of Helicobacter pylori infection in a European Country: the San Marino Study. Relations with gastrointestinal disease. Gut 1995;36:838-44.
22. Pretolani S, Figura N, Miglio F, Bonvicini F, Baldini L, Gatto MRA, et al. Association of Helicobacter pylori and anti CagA serum IgG with gastroduodenal endoscopie lesions in the population of San Marino (Abstract). Gut 1995;37(Suppl. 1):71.
23. Mégraud F, Brassens-Rabbe MP, Denis F, Belbouri A, Hoa DQ. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol 1989;27:1870-3.
24. Cover TL, Dooley CP, Blaser MJ. Characterization of and human sérologie response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxic activity. Infect Immun 1990;58:603-10.
25. Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991;6:209-22.
26. Smoot DT, Resau JH, Earlington MH, Simpson M, Cover TL. Effects of H. pylori vacuolating cytotoxin on primary cultures of human gastric epithelial cells. Gut 1996;39:795-9.
27. Crabtree JE, Taylor JD, Wyatt JI, Heatley RV, Shallcross TM, Tompkins DS, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulcération, and gastric pathology. Lancet 1991;338:332-5.
28. Peek RM jr, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, et al. Heightened inflammatory response and cytokine expression in vivo to CagA+ Helicobacter pylori strains. Lab Invest 1995;73:760-70.
29. Davies GR, Banatvala N, Collins CE, Sheaff MT, Abdi Y, Clements L, et al. Relationship between infection load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol 1994;29:419-24.
30. Mannick EE, Bravo LE, Zarama G, Realpe JL, Zhang XJ, Ruiz B, et al. Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res 1996;56:3238-43.
31. Hirai M, Azuma T, Ito S, Kato T, Kohli Y, Fujiki N. High prevalence of neutralizing activity to Helicobacter pylori cytotoxin in serum of gastric-carcinoma patients. Int J Cancer 1994;56:56-60.
32. Sipponen P, Riihela M, Hyvarinen H, Seppala K. Chronic nonatrophic ("superficial") gastritis increases the risk of gastric carcinoma. A case-control study. Scand J Gastroenterol 1994;29:336-40.
33. Miehlke S, Figura N, Kim JG, Small SM, Graham DY, Go MR Western blotting for detection of Helicobacter pylori anti-CagA antibodies strongly correlated with presence of the cagA gene. Gastroenterology 1996;110:A-121.
34. Cover TL, Glupczynski Y, Lage AP, Burette A, Tummuru MK, Perez-Perez GI, et al. Serologie detection of infection with CagA+ Helicobacter pylori strains. J Clin Microbiol 1995;33:1496500.
35. Graham DY, Genta RM, Graham DP, Crabtree JE. Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol 1996:49:829-32.
36. Sipponen P. Gastric cancer - a long-term consequence of Helicobacter pylori infection? Scand J Gastroenterol 1994;Suppl. 201:24-7.
37. Collins JS, Sloan JM, Hamilton PW, Watt PC, Love AH. Investigation of the relationship between gastric antral inflammation and Campylobacter pylori using graphic tablet planimetry. J Pathol 1989;159:281-5.
38. Collins JS, Hamilton PW, Watt PC, Sloan JM, Love AH. Superficial gastritis and Campylobacter pylori in dyspeptic patients - a quantitative study using computer-linked image analysis. J Pathol 1989;158:303-10.
39. Collins JS, Hamilton PW, Watt PC, Sloan JM, Love AH. Quantitative histological study of mucosal inflammatory cell densities in endoscopie duodenal biopsy specimens from dyspeptic patients using computer linked image analysis. Gut 1990;31:858-61.